NAIF 2.0 - COGNIFY Exploring Cognitive Impairment and Glymphatic Function Changes After Endovascular Treatment in Intracranial Dural Arteriovenous Fistula
Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2026-09-17
20
Participants Needed
3
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are exploring whether intracranial dural arteriovenous fistulae dAVF, abnormal connections between arteries and veins in the brains covering, affect the brains waste-clearance system called the glymphatic system. This observational study aims to understand if the glymphatic systems function changes after routine endovascular embolization treatment of dAVF, focusing on the possible link between venous drainage issues and cognitive impairment. The study builds on previous findings suggesting that cognitive problems in dAVF patients may improve after treatment, but the underlying biological reasons remain unclear.
Participants diagnosed with unruptured intracranial dAVF who are scheduled for endovascular embolization as part of their usual medical care will undergo advanced brain MRI scans at two time points before treatment and about six months afterward. The MRI protocol includes multiple imaging sequences, especially diffusion-weighted MRI techniques that assess glymphatic-related brain metrics such as DTI-ALPS, diffusion kurtosis imaging mean kurtosis DKI-MK, and free-water FW imaging. These measurements will help compare brain changes before and after embolization.
During the study, participants will have two brain MRI sessions using a 3T scanner to capture detailed brain images related to glymphatic function. Researchers will analyze changes in the MRI-derived metrics to evaluate glymphatic system function and its potential recovery after treatment. The primary outcomes are changes in DTI-ALPS, MK, and FW values between baseline and six months post-treatment. This study may provide new insights into cognitive changes associated with dAVF and offer a better understanding of treatment effects beyond traditional risk factors. Participation involves imaging assessments with no experimental treatments beyond routine care.
CONDITIONS
Brief Title
NAIF 2.0 - COGNIFY
Research Team
L
Laura Ludovica Gramegna, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Hospital Universitari Vall d'Hebron Research Institute
Lead Sponsor
University of Bologna
Collaborating Sponsor
Who Can Participate
Age: 18Years - 99Years
All Genders
Eligibility Criteria
You may qualify if you...
Participant is willing and able to give informed consent for participation in the study.
Male or Female, aged 18 to 99 years.
Angiographically confirmed diagnosis of unruptured intracranial dAVF.
Candidate for endovascular embolization treatment with curative intent.
Able to undergo Brain MRI.
You will not qualify if you...
Contraindication to angiographic embolization procedures.
Acute intracranial haemorrhage secondary to dAVFs rupture and/or venous hypertension.
Any significant disease or disorder which might influence the participant's ability to participate.
Contraindications to MRI such as certain metallic implants.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Imaging Assessments
Duration - Approximately 6 months
Participants undergo a brain MRI scan before their scheduled endovascular embolization treatment and another MRI about six months after treatment to assess brain changes related to glymphatic function.
2 MRI visits
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Studying Brain Imaging Changes Before and After Venous Sinus Stenting in Adults with Idiopathic Intracranial Hypertension
Study of Morning Bright Light Therapy to Improve Sleep and Brain Health in Adults with Traumatic Brain Injury
NAIF 2.0 - COGNIFY Exploring Cognitive Impairment and Glymphatic Function Changes After Endovascular Treatment in Intracranial Dural Arteriovenous Fistula
Study of a Wireless Headband Device to Improve Sleep Quality and Brain Function in Healthy Young Adults
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Cognitive improvement following endovascular embolization in patients with intracranial dural arteriovenous fistula: The Neuropsychology in dural ArterIal Fistula (NAIF) Study.
Laura Ludovica Gramegna, Gemma Ortega, Lavinia Dinia...
A "glympse" into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin-4 for the assessment of glymphatic system in Alzheimer's disease and other dementias.
Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases.